+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years +
All Genders
ID07441681

Comparing Radiation Therapy with Cetuximab Versus Chemotherapy Using Carboplatin and Paclitaxel for Advanced Head and Neck Cancer in Patients Unsuitable for Cisplatin

Led by NRG Oncology · Updated on 2026-10-27

454

Participants Needed

150

Research Sites

261 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating treatments for patients with advanced head and neck cancer that has spread locally or to distant parts and who cannot receive cisplatin. This phase III trial compares two approaches combined with intensity modulated radiation therapy IMRT cetuximab, a monoclonal antibody targeting EGFR on cancer cells, versus chemotherapy with carboplatin and paclitaxel. The study aims to determine which treatment better controls the cancer and improves survival while considering safety and quality of life. Participants are randomly assigned to one of two groups. One group receives IMRT five days per week for 35 treatments alongside cetuximab given intravenously as a loading dose before radiation and then weekly concurrent infusions for seven cycles. The other group receives the same IMRT schedule with weekly intravenous carboplatin and paclitaxel for seven cycles during radiation. Both groups undergo imaging scans like CT, MRI, or PETCT during screening and follow-up, as well as blood sample collections throughout the study. Participants are followed after treatment completion at 30 days, then at 4, 6, 12, 18, 24, 30, and 36 months, and annually thereafter. Researchers collect data on cancer progression, survival, treatment side effects, and changes in diet, eating, and speech. The main outcome measured is progression-free survival up to eight years, with additional monitoring of overall survival, adverse events, patterns of cancer recurrence, and quality of life changes over time.

CONDITIONS

Brief Title

Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Advanced Head and Neck Cancer Who Cannot Receive Cisplatin

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here